AI
ABBV icon

AXS Investments’s AbbVie ABBV Stock Holding History

AXS Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.7K Sell
269
-23
-8% -$4.95K 0.02% 151
2026
Q1 		$63.5K Sell
292
-85
-23% -$18.9K 0.03% 149
2025
Q4 		$86.1K Sell
377
-115
-23% -$26.2K 0.03% 153
2025
Q3 		$114K Buy
+492
New +$100K 0.04% 147
2025
Q2 		– Sell
-6,802
Closed -$1.43M – 146
2025
Q1 		$1.43M Sell
6,802
-1,342
-16% -$261K 0.39% 93
2024
Q4 		$1.45M Buy
8,144
+904
+12% +$166K 0.4% 92
2024
Q3 		$1.43M Sell
7,240
-879
-11% -$164K 0.38% 113
2024
Q2 		$1.39M Buy
8,119
+345
+4% +$57.1K 0.39% 90
2024
Q1 		$1.42M Sell
7,774
-1,756
-18% -$303K 0.34% 91
2023
Q4 		$1.48M Buy
9,530
+307
+3% +$44.8K 0.35% 81
2023
Q3 		$1.37M Buy
9,223
+8,115
+732% +$1.19M 0.35% 78
2023
Q2 		$149K Sell
1,108
-230
-17% -$33.7K 0.04% 281
2023
Q1 		$213K Buy
1,338
+217
+19% +$33.2K 0.07% 209
2022
Q4 		$181K Buy
+1,121
New +$172K 0.06% 200
2022
Q3 		– Sell
-1,813
Closed -$278K – 203
2022
Q2 		$278K Sell
1,813
-595
-25% -$90.9K 0.1% 190
2022
Q1 		$390K Sell
2,408
-1,627
-40% -$236K 0.16% 101
2021
Q4 		$546K Buy
+4,035
New +$477K 0.13% 108
2021
Q3 		– Sell
-4,628
Closed -$521K – 100
2021
Q2 		$521K Buy
4,628
+1,120
+32% +$126K 0.16% 116
2021
Q1 		$380K Buy
+3,508
New +$375K 0.14% 123

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AXS Investments's ABBV Position: Q2 2026 in Review

AXS Investments reduced its AbbVie (ABBV) stake by 7.9% in Q2 2026, selling an estimated $4.95K and leaving 269 shares worth $67.7K. The position accounts for 0.02% of the portfolio, ranked #151.

AXS Investments first reported a position in ABBV in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.48M in Q4 2023. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AXS Investments held 269 shares of AbbVie worth $67.7K as of Q2 2026.
  • AXS Investments sold 23 AbbVie shares in Q2 2026, an estimated $4.95K.
  • AbbVie made up 0.02% of AXS Investments's portfolio in Q2 2026, its #151 holding.
  • AXS Investments first reported a position in AbbVie in Q1 2021 and has held it in 19 quarters since.
  • AXS Investments's AbbVie position peaked at $1.48M in Q4 2023.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.